正壓通氣裝置市場規模、佔有率及成長分析(依產品類型、應用、最終用戶及地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1907688

正壓通氣裝置市場規模、佔有率及成長分析(依產品類型、應用、最終用戶及地區分類)-2026-2033年產業預測

Positive Airway Pressure Devices Market Size, Share, and Growth Analysis, By Product Type, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,正壓通氣 (PAP) 市場規模將達到 23.9 億美元,到 2025 年將達到 25.1 億美元,到 2033 年將達到 37.7 億美元,在預測期(2026-2033 年)內,複合年成長率為 5.2%。

全球正壓通氣(PAP)市場正經歷顯著成長,這主要得益於人們對睡眠呼吸中止症等睡眠相關呼吸障礙的認知和診斷水準的提高。這些疾病對整體健康有重大影響,因此對有效治療方法的需求日益成長。 PAP設備,特別是持續性正壓呼吸器(CPAP)和雙水平氣道正壓通氣(BiPAP),提供了一種非侵入性解決方案,可以改善呼吸功能並緩解症狀。市場成長的促進因素包括醫療費用支出的增加、設備技術的進步(旨在提高舒適度和功能性)以及人口老化導致患者更容易患上這些疾病。製造商、醫療保健提供者和研究機構之間的合作正在推動創新。然而,患者依從性、成本和監管因素等挑戰仍需要持續改善產品、擴大分銷管道並加強教育,以提高PAP療法的接受度。

正壓通氣裝置市場促進因素

全球睡眠障礙發生率的不斷上升是推動正壓通氣設備市場成長的主要因素。阻塞型睡眠呼吸中止症症等疾病需要有效的治療方案,而正壓通氣機是治療這些疾病的標準療法。預防睡眠期間的氣道阻塞對於緩解相關併發症至關重要。隨著睡眠相關疾病盛行率的持續上升,對可靠的正壓治療方案的需求預計將會增加,從而推動市場擴張,並鞏固這些設備在醫療保健領域的重要性。

限制正壓通氣輔助裝置市場的因素

正壓通氣輔助裝置(PAP)在治療睡眠呼吸障礙方面療效顯著,但許多患者面臨阻礙其持續使用的挑戰。面罩不適、配戴不合適、幽閉恐懼症等因素都會影響患者堅持治療。此外,對PAP治療長期健康益處的認知不足也會進一步阻礙患者繼續使用。解決這些依從性問題對於充分發揮PAP裝置的潛力並確保患者獲得良好的治療效果至關重要。因此,這項挑戰對PAP裝置市場的整體成長和成功有重大影響。

正壓通氣輔助裝置市場趨勢

正壓通氣(PAP)設備市場正呈現出顯著的趨勢,即整合遠端監測和遠端醫療解決方案。製造商正擴大將連接功能整合到設備中,使患者能夠輕鬆地與醫療服務提供者共用治療數據,從而實現即時回饋和個人化支援。這項進步提高了患者的治療依從性,進而改善了整體治療效果。隨著醫療保健產業逐步採用數位化解決方案,預計這一趨勢將進一步影響PAP設備市場,推動創新,並擴大睡眠呼吸中止症等疾病患者獲得有效治療的機會。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管環境
  • 專利分析
  • 技術分析

全球正壓通氣(PAP)市場規模(按產品類型和複合年成長率分類)(2026-2033 年)

  • 持續性呼吸道正壓通氣(CPAP)
  • 自動正壓通氣裝置(APAP)
  • 雙水平正壓通氣(BiPAP)

全球正壓通氣(PAP)市場規模(按應用及複合年成長率分類)(2026-2033年)

  • 阻塞型睡眠呼吸中止症症
  • 呼吸衰竭
  • 慢性阻塞性肺病(COPD)
  • 其他

全球正壓通氣(PAP)市場規模(依最終用戶分類)及複合年成長率(2026-2033 年)

  • 醫院
  • 居家醫療
  • 睡眠檢查室和診所

全球正壓通氣(PAP)市場規模(按地區分類)及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • ResMed Inc.(USA)
  • Koninklijke Philips NV(Netherlands)
  • Fisher & Paykel Healthcare Corporation Limited(New Zealand)
  • DeVilbiss Healthcare LLC(USA)
  • Drive Medical(USA)
  • 3B Medical, Inc.(USA)
  • Apex Medical Corp.(Taiwan)
  • BMC Medical Co., Ltd.(China)
  • Somnetics International, Inc.(USA)
  • Invacare Corporation(USA)
  • Medtronic plc(Ireland)
  • Vyaire Medical, Inc.(USA)
  • Compumedics Limited(Australia)
  • Lowenstein Medical Innovation GmbH & Co. KG(Germany)
  • Teijin Pharma Limited(Japan)
  • Nihon Kohden Corporation(Japan)
  • Itamar Medical Ltd.(Israel)
  • Circadiance LLC(USA)
  • Breas Medical AB(Sweden)
  • Weinmann Emergency Medical Technology GmbH+Co. KG(Germany)

結論與建議

簡介目錄
Product Code: SQMIG35A2480

Positive Airway Pressure Devices Market size was valued at USD 2.39 Billion in 2024 and is poised to grow from USD 2.51 Billion in 2025 to USD 3.77 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global market for Positive Airway Pressure (PAP) devices is experiencing significant growth, driven by heightened awareness and diagnosis of sleep-related breathing disorders like sleep apnea. These conditions greatly impact overall health, amplifying the demand for effective treatment options. PAP devices, particularly Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP), provide non-invasive solutions that enhance breathing and alleviate symptoms. Several factors fuel market expansion, including increasing healthcare spending, advancements in device technology for improved comfort and functionality, and a rising aging population susceptible to such disorders. Collaborations among manufacturers, healthcare providers, and research entities are fostering innovation. Nonetheless, challenges such as patient adherence, cost, and regulatory factors necessitate ongoing efforts in product refinement, distribution, and education to improve acceptance of PAP therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positive Airway Pressure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positive Airway Pressure Devices Market Segments Analysis

Global Positive Airway Pressure Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Continuous Positive Airway Pressure (CPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices and Bi-level Positive Airway Pressure (BiPAP) Devices. Based on Application, the market is segmented into Obstructive Sleep Apnea, Respiratory Failures, Chronic Obstructive Pulmonary Disease (COPD) and Others. Based on End User, the market is segmented into Hospitals, Home Healthcare and Sleep Laboratories & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positive Airway Pressure Devices Market

The growth of the positive airway pressure devices market is significantly driven by the rising incidence of sleep disorders globally. Conditions such as obstructive sleep apnea require effective treatment solutions, and positive airway pressure devices are considered the standard in managing these issues. By facilitating unobstructed airflow during sleep, they play a vital role in addressing the complications associated with these disorders. As the prevalence of sleep-related ailments continues to rise, the demand for reliable PAP therapy solutions is anticipated to increase, thereby propelling market expansion and solidifying the importance of these devices in the healthcare landscape.

Restraints in the Positive Airway Pressure Devices Market

While Positive Airway Pressure (PAP) devices are highly effective in managing sleep-related breathing disorders, many individuals encounter challenges that hinder their consistent use. Factors such as discomfort from masks, poor fit, and feelings of claustrophobia can discourage adherence to prescribed therapy. Additionally, a lack of understanding of the long-term health benefits associated with PAP treatment may further diminish motivation among patients to maintain their usage. Addressing these non-adherence issues is essential for maximizing the potential of PAP devices and ensuring favorable outcomes for patients. Consequently, this challenge significantly impacts the overall growth and success of the PAP device market.

Market Trends of the Positive Airway Pressure Devices Market

The Positive Airway Pressure (PAP) devices market is witnessing a significant trend towards the integration of remote monitoring and telehealth solutions. Manufacturers are increasingly embedding connectivity features in their devices, enabling patients to share therapy data with healthcare providers easily, which allows for real-time feedback and personalized support. This advancement enhances patient adherence to treatment, improving overall management and outcomes. As the healthcare sector progressively embraces digital solutions, this trend is poised to further influence the PAP devices market, fostering innovation and expanding access to effective therapy for patients managing conditions like sleep apnea.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis
  • Technology Analysis

Global Positive Airway Pressure Devices Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Automatic Positive Airway Pressure (APAP) Devices
  • Bi-level Positive Airway Pressure (BiPAP) Devices

Global Positive Airway Pressure Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Obstructive Sleep Apnea
  • Respiratory Failures
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others

Global Positive Airway Pressure Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Home Healthcare
  • Sleep Laboratories & Clinics

Global Positive Airway Pressure Devices Market Size & CAGR (2026-2033)

  • North America (Product Type, Application, End User)
    • US
    • Canada
  • Europe (Product Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • ResMed Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fisher & Paykel Healthcare Corporation Limited (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DeVilbiss Healthcare LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Drive Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3B Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apex Medical Corp. (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BMC Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Somnetics International, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invacare Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vyaire Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Compumedics Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lowenstein Medical Innovation GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teijin Pharma Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Itamar Medical Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Circadiance LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Breas Medical AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Weinmann Emergency Medical Technology GmbH + Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations